Actively Recruiting
Evaluating Safety and Effects of Single Dose UBT38006 Injection Compared to Insulin Controls in Healthy Adult Men with Type 2 Diabetes Risk
Led by The United Bio-Technology (Hengqin) Co., Ltd. · Updated on 2026-09-15
53
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single subcutaneous doses of UBT38006 injection in healthy adult males. This study includes 6 cohorts four dose-escalation groups receiving UBT38006 at varying doses 1, 3, 6, and 12 nmolkg, an active control group receiving insulin degludec, and another active control group receiving insulin icodec. The study is randomized, double-blind for the UBT38006 and placebo groups, and open-label for the active control groups. Participants receive a single subcutaneous injection of either UBT38006, placebo, insulin degludec, or insulin icodec, depending on their assigned cohort. Cohorts 1 to 4 have a double-blind design with participants randomized to UBT38006 or placebo, while cohorts 5 and 6 receive open-label active controls. The doses for active controls are 0.4 Ukg for insulin degludec and 1.25 Ukg for insulin icodec. During the study, participants are closely monitored for safety and tolerability, including local reactions at the injection site. Researchers assess pharmacokinetic and pharmacodynamic parameters, measuring multiple outcomes such as adverse events, glucose infusion rate, maximum concentration, and half-life from baseline up to 43 days post-dose. The trial only includes healthy adult males aged 18 to 45 years with specific weight and glucose criteria, and participation lasts through the follow-up period until day 43.
CONDITIONS
Brief Title
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males
Research Team
Y
Yu Huang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here